Keyphrases
Acquired Resistance
100%
ACK1
100%
Osimertinib
100%
EGFR-mutant NSCLC
100%
Third-generation EGFR Inhibitors
100%
NSCLC Cells
100%
Drug Effects
20%
Apoptosis Induction
20%
Western Blotting
20%
Colony Formation
20%
NSCLC Cell Lines
20%
Cell number
10%
Apoptosis
10%
Cell Growth
10%
Gene Knockout
10%
Quantitative PCR
10%
Receptor Tyrosine Kinase
10%
β-Galactosidase (β-Gal)
10%
Cell Response
10%
Flow Cytometry
10%
Protein Cleavage
10%
Intracellular Protein
10%
Mouse in Vivo
10%
Drug-resistant Tumor
10%
Annexin V
10%
Measuring Cell
10%
Resistant Cell Lines
10%
Cell Colony
10%
Induced Senescence
10%
Oncogenic Function
10%
Cell Senescence
10%
Innovative Strategies
10%
Xenograft Mice
10%
AZD9291
10%
Osimertinib Resistance
10%
Long-term Resistance
10%
Medicine and Dentistry
Epidermal Growth Factor Receptor
100%
Non-Small Cell Lung Cancer
100%
EGFR Inhibitors
100%
Osimertinib
100%
Programmed Cell Death
25%
In Vitro
16%
Drug Effect
16%
Cell Line
16%
Colony Formation
16%
Western Blotting
16%
Neoplasm
8%
Cell Growth
8%
Protein Tyrosine Kinase
8%
Cell Protein
8%
Flow Cytometry
8%
Xenograft
8%
Quantitative Reverse Transcription Polymerase Chain Reaction
8%
Galactosidase
8%
Lipocortin 5
8%
Cellular Senescence
8%
Protein Cleavage
8%
Gene Knockdown
8%
Resistant Cell Line
8%
Messenger RNA
8%
Biochemistry, Genetics and Molecular Biology
Epidermal Growth Factor Receptor
100%
Drug Effect
40%
Colony Formation
40%
Western Blotting
40%
Cell Growth
20%
Protein Cleavage
20%
Galactosidase
20%
Nude Mouse
20%
Cell Count
20%
Quantitative Reverse Transcription Polymerase Chain Reaction
20%
Non-Receptor Tyrosine Kinase
20%
Gene Knockdown
20%
Flow Cytometry
20%
Messenger RNA
20%
Lipocortin
20%
Pharmacology, Toxicology and Pharmaceutical Science
Epidermal Growth Factor Receptor
100%
Osimertinib
100%
Western Blot
16%
Neoplasm
8%
Protein Tyrosine Kinase
8%
Cell Protein
8%
Flow Cytometry
8%
Galactosidase
8%
Nude Mouse
8%
Lipocortin 5
8%
Messenger RNA
8%